DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Asimadoline is an investigational drug.
There have been 7 clinical trials for Asimadoline. The most recent clinical trial was a Phase 3 trial, which was initiated on May 1st 2010.
The most common disease conditions in clinical trials are Syndrome, Irritable Bowel Syndrome, and Diarrhea. The leading clinical trial sponsors are Tioga Pharmaceuticals, RTI Health Solutions, and Mayo Clinic.
Recent Clinical Trials for Asimadoline
|Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis||Tioga Pharmaceuticals||Phase 2|
|A Metabolite Identification, Mass Balance, and PK Study of [14C]-Asimadoline to Healthy Adult Male Volunteers||Tioga Pharmaceuticals||Phase 1|
|Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)||RTI Health Solutions||Phase 3|